Célia Dos Santos

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in<i>ex vivo</i>whole tumor tissue samples from patients

Maria Serova, Annemilaï Tijeras‐Raballand, Célia Dos Santos et al. · Oncotarget · 2015 · 98 citations · Full text

Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2

Hanneke van Zoggel, Gilles Carpentier, Célia Dos Santos et al. · PLoS ONE · 2012 · 82 citations · Full text

Antibiotic Adjuvant, Immunology, Cell Death +20

Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib

Maria Serova, Armand de Gramont, Annemilaï Tijeras‐Raballand et al. · Cancer Chemotherapy and Pharmacology · 2013 · 42 citations

Urology, Oncology, Medicine +5

Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans

Célia Dos Santos, Sabah Hamadat, Karen Le Saux et al. · PLoS ONE · 2017 · 40 citations · Full text

Immunology, Glycobiology, Dermatology +19

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib

Maria Serova, Annemilaï Tijeras‐Raballand, Célia Dos Santos et al. · Oncotarget · 2016 · 37 citations · Full text